Warp Drive Bio (Cambridge, MA) a development-stage biopharma company focused on a proprietary genomic search engine to identify and develop natural product drug candidates in microbes to target previously undruggable targests, closed a $75M Series A financing. Participants include Third Rock Ventures, Greylock Partners and Sanofi.